Clinical Trial Update: Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection [NA]

View source ↗

Summary

A two-stage study evaluating a single dose of PEGPH20 with cetuximab in pancreatic adenocarcinoma patients prior to surgical resection has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• PEGPH20 (pegylated hyaluronidase)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer | NA | Status: COMPLETED | Results posted: 2017-09-27